Prostaglandin (PG) E2 is a potential anti-inflammatory mediator that attenuates airway inflammation. To elucidate the functions of the PGE2 receptors (EP1, EP2, EP3, and EP4) in allergic inflammation, we examined the in vivo effects of EP agonists on mucus hypersecretion and eosinophil infiltration in rat nasal epithelium.
Methods:
We induced hypertrophic and metaplastic changes in goblet cells in nasal epithelium of ovalbumin-sensitized rats by intranasal challenge with ovalbumin. The effects of subcutaneous injections of EP agonists on mucus production and eosinophil infiltration were examined.
Results:
The EP4 agonist (1 to 100 μg/kg) dose-dependently inhibited ovalbumin-induced mucus production. The EP2 and EP3 agonists (100 μg/kg) also significantly inhibited mucus production. The EP3 agonist inhibited antigen-induced eosinophil infiltration, whereas the EP1 agonist showed no effect. This suppression of mucus production by the EP4 agonist was only effective when the EP4 agonist was given in the effector phase; administration in the induction phase resulted in no effect.
Conclusions:
These results indicate that PGE2 acts as an anti-inflammatory mediator via the EP receptors of airways in allergic inflammation. Selective EP agonists may provide a new therapeutic strategy for airway mucus hypersecretion.
BlythDIPedrickMSSavageTJHesselEMFattahD. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol1996;14:425–38.
2.
AgustiCTakeyamaKCardellLO. Goblet cell degranulation after antigen challenge in sensitized guinea pigs. Role of neutrophils. Am J Respir Crit Care Med1998;158:1253–8.
3.
SavoieCPlantMZwikkerM. Effect of dexamethasone on antigen-induced high molecular weight glycoconjugate secretion in allergic guinea pigs. Am J Respir Cell Mol Biol1995;13:133–43.
4.
HaileSLefortJJosephDGounonPHuerreMVargaftigBB. Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. Am J Respir Cell Mol Biol1999;20:891–902.
5.
ShimizuTHattoriRShimizuSKouzakiHMajimaY. Role of prostaglandin E2 as a protective mediator for allergic inflammation. Clin Exp Allergy Rev2007;7:36–40.
6.
MinakuchiRWacholtzMCDavisLSLipskyPE. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol1990;145:2616–25.
7.
IkegamiRSugimotoYSegiE. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J Immunol2001;166:4689–96.
8.
TakayamaKGarcía-CardenaGSukhovaGKComanderJGimbroneMAJrLibbyP. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem2002;277:44147–54.
9.
YamaneHSugimotoYTanakaSIchikawaA. Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun2000;278:224–48.
10.
VassiliouEJingHGaneaD. Prostaglandin E2 inhibits TNF production in murine bone marrow–derived dendritic cells. Cell Immunol2003;223:120–32.
11.
JingHVassiliouEGaneaD. Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J Leukoc Biol2003;74:868–79.
12.
GauvreauGMWatsonRMO'ByrnePM. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med1999;159:31–6.
13.
PavordIDWongCSWilliamsJTattersfieldAE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis1993;148:87–90.
14.
HartertTVDworskiRTMellenBGOatesJAMurrayJJSchellerJR. Prostaglandin E2 decreases allergen-stimulated release of prostaglandin D2 in airways of subjects with asthma. Am J Respir Crit Care Med2000;162:637–40.
15.
NarumiyaSSugimotoYUshikubiF. Prostanoid receptors: Structures, properties, and functions. Physiol Rev1999;79:1193–226.
16.
HattoriRShimizuSMajimaYShimizuT. EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells. Ann Otol Rhinol Laryngol2008;117:51–8.
17.
ShimizuTHiranoHMajimaYSakakuraY. A mechanism of antigen-induced mucus production in nasal epithelium of sensitized rats. A comparison with lipopolysaccharide-induced mucus production. Am J Respir Crit Care Med2000;161:1648–54.
18.
ShimizuTTakahashiYKawaguchiSSakakuraY. Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Respir Crit Care Med1996;153:1412–8.
19.
SuzawaTMiyauraCInadaM. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology2000;141:1554–9.
20.
KimYDKwonEJParkDWSongSYYoonSKBaekSH. Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. Mol Pharmacol2002;62:1112–8.
21.
GrayTNettesheimPLoftinC. Interleukin-1beta– induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP–protein kinase A signaling. Mol Pharmacol2004;66:337–46.
22.
TilleySLHartneyJMEriksonCJ. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol2003;284:L599–L606.
23.
ClarkeDLBelvisiMGCatleyMCYacoubMHNewtonRGiembyczMA. Identification in human airways smooth muscle cells of the prostanoid receptor and signaling pathway through which PGE2 inhibits the release of GM-CSF. Br J Pharmacol2004;141:1141–50.
24.
NatarajCThomasDWTilleySL. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J Clin Invest2001;108:1229–35.
25.
MitaHHasegawaMHigashiNAkiyamaK. Characterization of PGE2 receptor subtypes in human eosinophils. J Allergy Clin Immunol2002;110:457–9.
26.
KasaiKSatoSSuzukiK. A novel prostaglandin E receptor subtype agonist, ONO-4819, attenuates acute experimental liver injury in rats. Hepatol Res2001;21:252–60.
27.
SakamotoAMatsumuraJMiiSGotohYOgawaR. A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production. Shock2004;22:76–81.
28.
KunikataTYamaneHSegiE. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol2005;6:524–31.
29.
NguyenMSolleMAudolyLP. Receptors and signaling mechanisms required for prostaglandin E2–mediated regulation of mast cell degranulation and IL-6 production. J Immunol2002;169:4586–93.
